Aevitas Wealth Management, Inc. Gilead Sciences, Inc. Transaction History

Aevitas Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $130,360 - $146,183	-2,107 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $687 - $770	11 Added 0.52%	2,107 $136,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $103,402 - $134,932	-1,708 Reduced 44.9%	2,096 $131,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $6,343 - $7,023	-89 Reduced 2.29%	3,804 $294,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $33,542 - $39,126	-517 Reduced 11.72%	3,893 $276,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $61,841 - $75,391	-849 Reduced 16.14%	4,410 $332,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $374,177 - $439,231	5,259	5,259 $377,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aevitas Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Aevitas Wealth Management, Inc. with notifications on news.